The EPS projection of Elizabeth Arden, Inc. (NASDAQ:RDEN) for quarter ended 2016-09-30 is $0.01. Last week, the EPS forecast was $0.01 against target of $0.01, a month earlier. Two months ago, this estimate was $0.01 versus forecast of $0.01 three months earlier, implying a deviation of 0%.
Elizabeth Arden, Inc. (NASDAQ:RDEN) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Elizabeth Arden, Inc. (NASDAQ:RDEN) in the preceding 30, 120, 60 and 90 days were 0, 2, 2, and 2, correspondingly.
Elizabeth Arden, Inc. (NASDAQ:RDEN) EPS target for the quarter closed 3 was $0.01, based on 3 recommendations. As reported on 2016-05-05 the EPS was $-0.59. The change was $0.15, implying a percentage deviation of 20.27%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Elizabeth Arden, Inc. (NASDAQ:RDEN) yearly sales prediction for the fiscal 2017 stands at $202.9 and the median estimate is at $202.9. Almost 2 analysts issued sales target.
Highest sales target is $207.7 while the lowest target is $198.1 showing standard deviation of 6.788%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of -0.294%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Elizabeth Arden, Inc. (NASDAQ:RDEN) announced that the deviation in forecast was 1.568%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...